Clinical Implication of Concurrent Amplification of MET and FGFR2 in Metastatic Gastric Cancer.

Seonggyu ByeonJaeyun JungSeung Tae KimKyoung-Mee KimJeeyun Lee

Published in: Biomedicines (2023)

our findings suggest that concurrent amplification of FGFR2 and MET in GC patients is associated with clinical aggressiveness and may contribute to non-responsiveness to chemotherapy or targeted therapy.

Keyphrases

locally advanced
end stage renal disease
ejection fraction
squamous cell carcinoma
newly diagnosed
chronic kidney disease
nucleic acid
tyrosine kinase
peritoneal dialysis
prognostic factors
mass spectrometry